Oncompass GmbH develops AI-based medical software to select molecularly targeted treatment options for cancer patients. It offers a Precision Oncology Program including digital therapy planning, molecular diagnostics, online and in-person consultations, and clinical tools such as virtual molecular tumor boards and oncology software.
AI-generated
Offering
Products & services
Industry:Medical LaboratoriesSoftware Development
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Precision Oncology Program for selecting personalised cancer therapies; includes consulting, programme planning, sample logistics, molecular diagnostics, digital therapy planning and follow-up support.
Molecular diagnostics
Molecular diagnostics for identifying disease-causing genetic alterations; analysis of tumour or blood samples with modern diagnostic methods for treatment decision-making.
Digital therapy planning
Digital therapy planning for personalised planning of treatments and immunotherapies; evaluation of genetic and clinical data, prioritisation of targeted therapies and preparation of a Precision-Oncology-Report.
Online consultation
Online consultation for patients and relatives to assess personalised therapy options; discussion of clinical data, prior molecular diagnostics and questions about the treatment strategy.
In-person consultation
In-person consultation for assessing personalised therapy options and explaining the programme; without physical examination, based on clinical data and prior diagnostic findings.
Virtual Molecular Tumor Board
Virtual Molecular Tumor Board for interdisciplinary case discussions; selection of the required molecular diagnostic tests, treatment planning based on molecular results and support for treatment decision-making.
Oncology software
Oncology software for selecting molecularly based targeted treatment options; supports oncologists with scientific evidence, decision rules and prioritisation of personalised therapies.
Precision oncology opinion
Precision oncology opinion for conveying results by specialist oncologists; discussion of personalised therapy options based on molecular findings and clinical data.
Therapy Access Program (TAP)
Therapy Access Program (TAP) to support access to off-label treatments and clinical trials; includes specialist, logistical and organisational tasks for patients and physician teams.
Comparisons
Oncompass GmbH in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Oncompass GmbH by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once Oncompass GmbH has claimed this profile, we'll publish editorial articles and case studies here together.